In our research, we demonstrated that the expression of PUMA is triggered by trastuzumab via the GSK‐3β/NF‐κB pathway subsequent to AKT suppression and triggers cell apoptosis depending on the number of mitochondria in GC cells. This evidence concerns the gene BBC3 and gastric cancer.